Calcium channel blockers are associated with improved survival and lower cardiovascular mortality in patients with renovascular disease

ConclusionsCalcium channel blockers are associated with significantly increased survival and lower cardiovascular mortality particularly in patients with moderate RAS disease.

Source: Cardiovascular Therapeutics - December 4, 2018 Category: Cardiology Authors: Harshal Deshmukh, Emma Barker, Thineshkrishna Anbarasan, Daniel Levin, Samira Bell, Miles D. Witham, Jacob George Tags: ORIGINAL RESEARCH ARTICLE Source Type: research